Anavex Other Operating Expenses from 2010 to 2024

AVXL Stock  USD 9.03  0.01  0.11%   
Anavex Life Other Operating Expenses yearly trend continues to be quite stable with very little volatility. Other Operating Expenses may rise above about 67.3 M this year. Other Operating Expenses is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. View All Fundamentals
 
Other Operating Expenses  
First Reported
2004-12-31
Previous Quarter
12.5 M
Current Value
14.7 M
Quarterly Volatility
4.6 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Anavex Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Anavex Life's main balance sheet or income statement drivers, such as Interest Expense of 1.3 M, Other Operating Expenses of 67.3 M or Total Operating Expenses of 67.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 3.48. Anavex financial statements analysis is a perfect complement when working with Anavex Life Valuation or Volatility modules.
  
Check out the analysis of Anavex Life Correlation against competitors.

Latest Anavex Life's Other Operating Expenses Growth Pattern

Below is the plot of the Other Operating Expenses of Anavex Life Sciences over the last few years. Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Anavex Life Sciences. It is also known as Anavex Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. It is expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production. Anavex Life's Other Operating Expenses historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Anavex Life's overall financial position and show how it may be relating to other accounts over time.
Other Operating Expenses10 Years Trend
Slightly volatile
   Other Operating Expenses   
       Timeline  

Anavex Other Operating Expenses Regression Statistics

Arithmetic Mean27,068,092
Geometric Mean11,232,731
Coefficient Of Variation87.33
Mean Deviation20,053,783
Median19,184,536
Standard Deviation23,637,234
Sample Variance558.7T
Range67.3M
R-Value0.97
Mean Square Error32T
R-Squared0.95
Slope5,143,175
Total Sum of Squares7822.1T

Anavex Other Operating Expenses History

202467.3 M
202364.1 M
202255.8 M
202151 M
202041.9 M
201930.9 M
201828.8 M

About Anavex Life Financial Statements

Anavex Life investors utilize fundamental indicators, such as Other Operating Expenses, to predict how Anavex Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Other Operating Expenses64.1 M67.3 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Anavex Life Sciences is a strong investment it is important to analyze Anavex Life's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Anavex Life's future performance. For an informed investment choice regarding Anavex Stock, refer to the following important reports:
Check out the analysis of Anavex Life Correlation against competitors.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anavex Life. If investors know Anavex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anavex Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.51)
Return On Assets
(0.20)
Return On Equity
(0.30)
The market value of Anavex Life Sciences is measured differently than its book value, which is the value of Anavex that is recorded on the company's balance sheet. Investors also form their own opinion of Anavex Life's value that differs from its market value or its book value, called intrinsic value, which is Anavex Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anavex Life's market value can be influenced by many factors that don't directly affect Anavex Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anavex Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Anavex Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anavex Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.